Absci grants stock options to new hire under Nasdaq inducement rule at $4.92 per share.

Absci Corporation awarded a non-statutory stock option for 276,200 shares to a newly hired non-executive employee as an inducement to join the company. The grant was approved under Absci's 2023 Inducement Plan and complies with Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $4.92 per share, matching the closing price on May 1, 2026, and vest over four years with a 10-year term. This move aims to attract talent to support Absci's AI-driven drug discovery efforts and ongoing development of innovative therapeutics like ABS-201 for hair regrowth and endometriosis.